N. Maskell (Bristol (Avon), United Kingdom), K. Blyth (Glasgow (Glasgow), United Kingdom)
Late Breaking Abstract - Comparison of VATS debulking surgery and HITHOC vs VATS talc pleurodesis alone in malignant pleural mesothelioma: a pilot study
M. Migliore (Catania, Italy), M. Nardini (Catania, Italy), A. Meli (Catania, Italy), C. Spatola (Catania, Italy), I. Monte (Catania, Italy), T. Nicolosi (Catania (CT), Italy), M. Scuderi (Catania (CT), Italy), H. Soto Parra (Catania , Italy), M. Aiello (Catania , Italy), P. Vigneri (Catania, Italy), G. Fantaci (Palermo , Italy)
|     |
BAP1 loss predicts longer survival for mesothelioma patients treated with pemetrexed-based chemotherapy.
V. Panou (Odense & Aalborg, Denmark), A. Louw (Perth, Australia), W. Szejniuk (Aalborg, Denmark), C. Meristoudis (Aalborg, Denmark), S. Chai (Perth, Australia), L. Lynggård Andersen (Aalborg, Denmark), A. Birbaneh Asghari (Aalborg, Denmark), M. Vyberg (Aalborg, Denmark), J. Hansen (Copenhagen, Denmark), J. Creaney (Perth, Australia), O. Røe (Levanger & Trondheim, Norway)
| |
Validation of LENT and PROMISE scores in malignant pleural effusion in an Asian population
C. Wong (Hong Kong, Hong Kong), W. Wong (Hong Kong, Hong Kong), K. So (Hong Kong, Hong Kong), Y. Yam (Hong Kong, Hong Kong)
| |
The association between pleural fluid exposure and survival in malignant pleural mesothelioma: a retrospective cohort study in 761 patients
R. Asciak (Oxford, United Kingdom), N. Kanellakis (Oxford, United Kingdom), A. Kidd (Glasgow, United Kingdom), A. Bibby (Bristol, United Kingdom), N. Maskell (Bristol, United Kingdom), K. Blyth (Glasgow, United Kingdom), R. Mercer (Oxford, United Kingdom), P. Fsadni (Msida, Malta), S. Montefort (Msida, Malta), I. Psallidas (Oxford, United Kingdom), N. Rahman (Oxford, United Kingdom)
| |
Utility of pleural fluid for predictive marker testing in malignant pleural effusion
J. Ferguson (Glasgow, United Kingdom), C. Craig (Manchester, United Kingdom), V. Randles (Cheshire, United Kingdom), T. Taylor (Cheshire, United Kingdom), L. Brown (Manchester, United Kingdom), D. Fullerton (Cheshire, United Kingdom), M. Evison (Manchester, United Kingdom), K. Blyth (Glasgow, United Kingdom), S. Tsim (Glasgow, United Kingdom)
| |
Studying the biological properties of pleural fluid: pleural fluid alone is adequate for cancer cell proliferation in vitro
R. Asciak (Oxford, United Kingdom), N. Kanellakis (Oxford, United Kingdom), X. Yao (Oxford, United Kingdom), M. Abd Hamid (Oxford, United Kingdom), T. Dong (Oxford, United Kingdom), R. Mercer (Oxford, United Kingdom), M. Hassan (Oxford, United Kingdom), E. Bedawi (Oxford, United Kingdom), M. Dobson (Oxford, United Kingdom), S. Montefort (Msida, Malta), P. Fsadni (Msida, Malta), N. Rahman (Oxford, United Kingdom), I. Psallidas (Oxford, United Kingdom)
| |
Preliminary Results of the Meso-ORIGINS Feasibility Study
K. Ferguson (Glasgow, United Kingdom), J. Ferguson (Glasgow, United Kingdom), S. Tsim (Glasgow, United Kingdom), R. Mercer (Oxford, United Kingdom), N. Rahman (Oxford, United Kingdom), N. Maskell (Bristol, United Kingdom), M. Evison (Manchester, United Kingdom), K. Blyth (Glasgow, United Kingdom)
| |
A Study of physical activity and sedentary behaviour in patients with malignant pleural effusion undergoing therapeutic interventions: ASPIRE
R. Banka (Oxford, United Kingdom), O. Castro-Anon (Oxford, United Kingdom), M. Hassan (Oxford, United Kingdom), E. Bedawi (Oxford, United Kingdom), R. Mercer (Oxford, United Kingdom), R. Asciak (Oxford, United Kingdom), R. Hallifax (Oxford, United Kingdom), V. George (Oxford, United Kingdom), J. Wrightson (Oxford, United Kingdom), N. Rahman (Oxford, United Kingdom)
| |